A design space exploration for control of Critical Quality Attributes of mAb

详细信息    查看全文

• 作者：Hemlata Bhatia^a ; Erik Read^b ; ¹ ; Cyrus Agarabi^b ; ¹ ; Kurt Brorson^b ; ¹ ; Scott Lute^b ; ¹ ; Seongkyu Yoon^a ; ^{seongkyu_yoon@uml.edu" class="auth_mail" title="E-mail the corresponding author}
• 关键词：Design space ; Critical quality attribute ; Critical process parameter
• 刊名：International Journal of Pharmaceutics
• 出版年：2016
• 出版时间：15 October 2016
• 年：2016
• 卷：512
• 期：1
• 页码：242-252
• 全文大小：2842 K

文摘

A unique “design space (DSp) exploration strategy,” defined as a function of four key scenarios, was successfully integrated and validated to enhance the DSp building exercise, by increasing the accuracy of analyses and interpretation of processed data. The four key scenarios, defining the strategy, were based on cumulative analyses of individual models developed for the Critical Quality Attributes (23 Glycan Profiles) considered for the study. The analyses of the CQA estimates and model performances were interpreted as (1) Inside Specification/Significant Model (2) Inside Specification/Non-significant Model (3) Outside Specification/Significant Model (4) Outside Specification/Non-significant Model. Each scenario was defined and illustrated through individual models of CQA aligning the description. The R², Q², Model Validity and Model Reproducibility estimates of G2, G2FaGbGN, G0 and G2FaG2, respectively, signified the four scenarios stated above. Through further optimizations, including the estimation of Edge of Failure and Set Point Analysis, wider and accurate DSps were created for each scenario, establishing critical functional relationship between Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs). A DSp provides the optimal region for systematic evaluation, mechanistic understanding and refining of a QbD approach. DSp exploration strategy will aid the critical process of consistently and reproducibly achieving predefined quality of a product throughout its lifecycle.